| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
|
J Natl Cancer Inst
|
2010
|
4.54
|
|
2
|
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
|
Nat Genet
|
2013
|
4.35
|
|
3
|
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
|
Am J Hum Genet
|
2008
|
3.41
|
|
4
|
BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy.
|
J Clin Oncol
|
2008
|
2.45
|
|
5
|
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.99
|
|
6
|
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
|
Cancer Res
|
2010
|
1.90
|
|
7
|
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
|
PLoS Genet
|
2013
|
1.88
|
|
8
|
19p13.1 is a triple-negative-specific breast cancer susceptibility locus.
|
Cancer Res
|
2012
|
1.81
|
|
9
|
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
|
PLoS Genet
|
2010
|
1.56
|
|
10
|
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
|
Hum Mol Genet
|
2011
|
1.56
|
|
11
|
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
|
Hum Mol Genet
|
2011
|
1.51
|
|
12
|
Clinical genetic testing for familial melanoma in Italy: a cooperative study.
|
J Am Acad Dermatol
|
2009
|
1.45
|
|
13
|
Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.
|
Hum Mutat
|
2010
|
1.45
|
|
14
|
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
|
J Natl Cancer Inst
|
2010
|
1.41
|
|
15
|
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.23
|
|
16
|
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.17
|
|
17
|
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
|
PLoS One
|
2012
|
1.13
|
|
18
|
PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer.
|
Breast Cancer Res Treat
|
2010
|
0.99
|
|
19
|
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.
|
Breast Cancer Res
|
2014
|
0.99
|
|
20
|
Comparative in vitro and in silico analyses of variants in splicing regions of BRCA1 and BRCA2 genes and characterization of novel pathogenic mutations.
|
PLoS One
|
2013
|
0.98
|
|
21
|
Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
|
Ann Surg Oncol
|
2009
|
0.94
|
|
22
|
SNPs in ultraconserved elements and familial breast cancer risk.
|
Carcinogenesis
|
2009
|
0.92
|
|
23
|
No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women.
|
Breast Cancer Res Treat
|
2010
|
0.92
|
|
24
|
Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
|
Hum Mutat
|
2012
|
0.92
|
|
25
|
Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
|
Eur J Cancer
|
2007
|
0.92
|
|
26
|
The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain.
|
J Med Genet
|
2011
|
0.91
|
|
27
|
Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases.
|
Breast Cancer Res Treat
|
2008
|
0.90
|
|
28
|
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
|
J Natl Cancer Inst
|
2015
|
0.90
|
|
29
|
Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.
|
Breast Cancer Res Treat
|
2012
|
0.90
|
|
30
|
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
|
Exp Dermatol
|
2012
|
0.90
|
|
31
|
The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.
|
Breast Cancer Res Treat
|
2010
|
0.89
|
|
32
|
The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians.
|
Breast Cancer Res Treat
|
2012
|
0.88
|
|
33
|
Novel MC1R variants in Ligurian melanoma patients and controls.
|
Hum Mutat
|
2004
|
0.88
|
|
34
|
High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families.
|
Am J Med Genet
|
2002
|
0.88
|
|
35
|
Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases.
|
PLoS One
|
2012
|
0.85
|
|
36
|
Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.
|
Breast Cancer Res Treat
|
2012
|
0.82
|
|
37
|
A BRCA1 promoter variant (rs11655505) and breast cancer risk.
|
J Med Genet
|
2010
|
0.81
|
|
38
|
Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.
|
Genes Chromosomes Cancer
|
2014
|
0.81
|
|
39
|
Exploring the link between MORF4L1 and risk of breast cancer.
|
Breast Cancer Res
|
2011
|
0.79
|
|
40
|
Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families.
|
Fam Cancer
|
2011
|
0.78
|
|
41
|
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients.
|
Melanoma Res
|
2004
|
0.78
|
|
42
|
Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics.
|
Breast Cancer Res Treat
|
2010
|
0.77
|
|
43
|
Evidence for a link between TNFRSF11A and risk of breast cancer.
|
Breast Cancer Res Treat
|
2011
|
0.77
|
|
44
|
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
|
J Natl Cancer Inst
|
2017
|
0.75
|
|
45
|
[The sustainability of the genetic data and biological samples].
|
Ig Sanita Pubbl
|
2009
|
0.75
|